Emblem is licensed under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR") to cultivate and sell medical marijuana. Emblem carries out its principal activities producing marijuana from its facilities in Paris, Ontario pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.
EMMBF Detailed Quote
|Day's Range:||1.7500 - 1.8800|
|52wk Range:||1.5467 - 3.8100|
EMMBF Recent Headlines
- How Investors Can Generate Higher Returns From the January Effect 01/04/2017 05:00 PM
- Emblem Corp. Gets Green Light from Health Canada to Begin Production of Cannabis Oils 12/19/2016 01:30 PM[Marketwired] - Emblem Corp. is pleased to announce that it has received confirmation from Health Canada that its license under the ACMPR will be amended to permit the production of cannabis oils.
- Emblem Provides Shareholder Update 12/15/2016 03:42 PM[Marketwired] - Emblem Corp. is pleased to provide an update to shareholders reviewing our accomplishments to date and our plans going forward in 2017.